Ornopia, Shanlee .

HRN: 28-69-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/17/2026
03/24/2026
PO
3ml
BID
Impetigo
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines